Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | BCL2A1 |
| Upstream (Parents) |
|---|
| (<<) ALOX5AP → BCL2A1 |
| (<<) C5AR1 → BCL2A1 |
| (<<) TREM1 → BCL2A1 |
| (<<) NCF2 → BCL2A1 |
| (<<) IL8 → BCL2A1 |
| (<<) FGR → BCL2A1 |
| (<<) PLAUR → BCL2A1 |
| Downstream (Children) |
|---|
| BCL2A1 → ALOX5AP (>>) |
| BCL2A1 → FOLR3 (>>) |
| BCL2A1 → CALB2 (>>) |
| BCL2A1 → PACSIN3 (>>) |
| BCL2A1 → CSF2RA (>>) |
| BCL2A1 → IL1B (>>) |
| BCL2A1 → TREM1 (>>) |
| BCL2A1 → KDM4B (>>) |
| BCL2A1 → UPP1 (>>) |
| BCL2A1 → CCL7 (>>) |
| BCL2A1 → RAC2 (>>) |
| BCL2A1 → IL8 (>>) |
| BCL2A1 → ZNF682 (>>) |
| BCL2A1 → SLC2A3 (>>) |
| BCL2A1 → MMP8 (>>) |
| BCL2A1 → GPR109B (>>) |
| BCL2A1 → KCNJ18///LOC100131509///KCNJ12 (>>) |
| BCL2A1 → TM7SF4 (>>) |
| BCL2A1 → PHACTR1 (>>) |
| BCL2A1 → PHF2 (>>) |
| BCL2A1 → HLA-G (>>) |
| BCL2A1 → FAM5B (>>) |
| BCL2A1 → HSPA6 (>>) |
